Current OTC pediatric dosing regimens considered "too broad" by AAP committee.
This article was originally published in The Tan Sheet
Executive Summary
CURRENT OTC PEDIATRIC DOSING REGIMENS CONSIDERED "TOO BROAD" by the American Academy of Pediatrics' Committee on Drugs, AAP committee chair Cheston Berlin, MD, told FDA's Nonprescription Drugs Advisory Committee on Jan. 13. Referring to the dosing schedule used for many pediatric cough/cold products, Berlin said the "current dosing approach, we believe, is too broad."